CompletedNCT00685334
Olanzapine or aripiprazole for anorexia
About this title
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
Read the official source — NCT00685334Medication studyAges 16+Canada + United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: from 16 years.
- Listed locations
- New York and 1 more locationSee all locations and recruitment
- Participation duration
- 12 weeks
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Medical follow-up
- Weekly visits with the study doctor during 12 weeks of treatment
Study information
Study start dateNovember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 22
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States, Canada
- Age range
- Over 16 Years
- Official registry ID
- NCT00685334
- Official title
Show the full official title
Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
Get this study by email
Recruitment & locations
CompletedNew York, United States · Toronto, Canada
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine and Aripiprazole.
Who was this study for?
Listed age limits: from 16 years.
